These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1619497)

  • 1. Introduction to a structural basis for renal and vascular complications in diabetes and hypertension.
    Viberti GC
    J Hypertens Suppl; 1992 Apr; 10(1):S1-4. PubMed ID: 1619497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and the renal vascular complications of diabetes: a structural basis to guide management.
    Viberti GC
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1938-40. PubMed ID: 7973521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and diabetes mellitus.
    Marre M; Berrut G; Bouhanick B
    Biomed Pharmacother; 1993; 47(2-3):61-6. PubMed ID: 8218950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition reduces diabetes-induced vascular hypertrophy: morphometric studies.
    Vranes D; Cooper ME; Dilley RJ
    J Vasc Res; 1995; 32(3):183-9. PubMed ID: 7772678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.
    Nosadini R; Abaterusso C; Dalla Vestra M; Bortoloso E; Saller A; Bruseghin M; Sfriso A; Trevisan M
    Nephrol Dial Transplant; 1998; 13 Suppl 8():44-8. PubMed ID: 9870425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
    Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M
    J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.
    Baba T; Neugebauer S; Watanabe T
    Drugs; 1997 Aug; 54(2):197-234. PubMed ID: 9257079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
    Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
    J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
    de la Sierra A; Salazar J
    Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension and diabetes mellitus: value of converting enzyme inhibitors].
    Passa P
    Bull Acad Natl Med; 1988 Feb; 172(2):205-10. PubMed ID: 3042105
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modulation of renin-angiotensin system for vascular protection in hypertensive patients and in patients with diabetic nephropathy].
    Gómez-Fernández P
    Rev Clin Esp; 2004 Nov; 204(11):596-600. PubMed ID: 15511408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Converting enzyme inhibitors in diabetes].
    Marre M
    Rev Prat; 1992 Dec; 42(20):2574-7. PubMed ID: 1299943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal lesions in the diabetic patient].
    Lagrue G
    Sem Hop Ther; 1973 Sep; 49 Spec No():103-6. PubMed ID: 4804044
    [No Abstract]   [Full Text] [Related]  

  • 15. Microvascular hemodynamics in hypertension and diabetes.
    Tooke JE; Sandeman DD; Shore AC
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S51-3. PubMed ID: 1725043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of diabetic renal and cardiovascular disease.
    Viberti GC
    Acta Diabetol Lat; 1990; 27(3):267-76. PubMed ID: 2075790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 18. Small artery remodeling in diabetes mellitus.
    Rizzoni D; Rosei EA
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):587-92. PubMed ID: 19481431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and diabetes.
    Jandeleit-Dahm K; Cooper ME
    Curr Opin Nephrol Hypertens; 2002 Mar; 11(2):221-8. PubMed ID: 11856916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.
    Burnier M; Zanchi A
    J Hypertens; 2006 Jan; 24(1):11-25. PubMed ID: 16331093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.